TAK-505 Clinical Trials (2026): 1 Studies for Malignant Solid Tumors
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 TAK-505 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Malignant Solid Tumors) and 151 total planned enrollment. 1 TAK-505 clinical trial is actively recruiting at 2 U.S. sites across 2 states. Most recent activity: NCT07436728 (Aug 2030).
Where to Participate: All TAK-505 Trial Sites in the U.S. (2 sites across 2 states)
Every actively recruiting TAK-505trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| TX | NEXT Oncology | San Antonio78229 | NCT07436728 | Map |
| VA | NEXT Oncology | Fairfax22031 | NCT07436728 | Map |
TAK-505 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1/P2 | 1 | 1 |
Recruiting TAK-505 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07436728 | A Study of TAK-505 in Adults With Solid Tumors | P1/P2 | Malignant Solid Tumors | 151 | May 2026 |
All TAK-505 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07436728 | A Study of TAK-505 in Adults With Solid Tumors | P1/P2 | recruiting | 151 | Takeda | May 2026 |
TAK-505 clinical trials: frequently asked questions
- How many TAK-505 clinical trials are there?
- 1 TAK-505 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are TAK-505 clinical trials recruiting in 2026?
- Yes — 1 TAK-505 trial is actively recruiting in 2026, with 2 U.S. sites across 2 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is TAK-505 being studied for?
- TAK-505 is being studied for Malignant Solid Tumors. The trials are grouped by indication on this page.
- Who sponsors TAK-505 clinical trials?
- The lead sponsor across the most TAK-505 trials is Takeda. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming TAK-505as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: